Medical device reform

In FY25, Australia’s Medical Device Reforms, including the General Use Items (GUI) reform, prioritised addressing rising costs and usage concerns within the Prescribed List (PL). Following the government’s decision to retain GUIs beyond July 2024, a national consultation was launched to explore more sustainable funding and usage models. We have actively responded to this process, providing evidence on the ongoing impacts and implications of the current arrangements.  We continue to advocate for meaningful change and remain committed to returning medical device reform savings to our customers through lower premium increases, helping to ensure healthcare remains affordable for all Australians.